is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Minneapolis, MN, United States – January 9, 2020 – 3.5 billion people are afflicted by dental disease, worldwide. The effects of cavities, periodontal disease and edentulism are profound and are now in the top 10 leading causes of years lived with disability (YLDs).* This Minnesota start-up is taking a completely new approach to address the root cause of these oral diseases - oral dysbiosis.
Primal Health, LLC is a biotechnology company with a pipeline of patented prebiotics for improved oral microbiome control for use in human and animal dental health. The breakthrough products are clinically-proven to inhibit oral pathogen growth and promote beneficial commensal growth for improved dental hygiene.
The Company was founded by Dr. Emily Stein, PhD, after witnessing the life-threatening illness of her grandmother as a direct result of dental disease. Dr. Stein has been working since 2010 on solving the problem of dental disease and the chronic systemic diseases that result from it. Dr. Stein earned her PhD in microbiology from UC Berkeley and her fellowship in Rheumatology and Immunology at Stanford University.
All are welcome to stop by Booth #H1.G19 to learn more about the company’s technology.